ArticleBMC pulmonary medicine2023

Tofacitinib in the treatment of primary Sjögren's syndrome-associated interstitial lung disease: study protocol for a prospective, randomized, controlled and open-label trial.

Ronglin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.